Press Releases
12/21/11- Etubics Ad5 Platform Overcomes Ad5 Immunity in Multiple Studies
10/13/11- Etubics HIV Vaccine Overcomes Ad5 Immunity in Ad5 Immunized Non-Human Primates
9/22/11- Etubics Awarded Contract for Nearly $1.7 Million for Colon and Breast Cancer Programs
8/16/11- Etubics H1N1 Vaccine Inhibits Horizontal Transmission in Ferrets
7/5/11- Etubics Awarded Grant for HPV Inducted Cancer Immunotherapy
4/29/11- Etubics AVVP for Breast Cancer Inhibits Tumor Progressing In Pre-Clinical Trial
11/5/10 - Etubics Presents at National Cancer Institute's SBIR Investor Forum at Stanford
11/2/10 - Etubics Awarded $244,479 Grant from United States Government Qualifying Therapeutic Discovery Project
9/27/10 - Etubics Presents at AIDS Vaccine Conference in Atlanta
07/28/10 - Etubics Enters Phase I Cancer Clinical Trials Focused on Colorectal Cancer
03/11/10 - Etubics Presents "Next Generation" of Adenovirus Vaccine at Life Science Innovation Northwest
01/08/10 - Etubics Presents "Next Generation" of Adenovirus Vaccine at Biotech Showcase
08/23/07 - Etubics Awarded Grant from the National Institute of Health for Continued Development of HIV Vaccine